IDEXX Laboratories Files 8-K on Financials
Ticker: IDXX · Form: 8-K · Filed: May 1, 2024 · CIK: 874716
| Field | Detail |
|---|---|
| Company | Idexx Laboratories Inc /De (IDXX) |
| Form Type | 8-K |
| Filed Date | May 1, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.10 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, sec-filing
TL;DR
IDEXX filed an 8-K on May 1st, expect financial updates soon.
AI Summary
On May 1, 2024, IDEXX Laboratories, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or operational details were provided in the excerpt.
Why It Matters
This 8-K filing indicates that IDEXX Laboratories is providing updates on its financial performance and condition to the SEC, which is important for investors to monitor the company's health.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any immediate negative news or significant changes.
Key Players & Entities
- IDEXX LABORATORIES, INC. (company) — Registrant
- May 1, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 000-19271 (identifier) — Commission File Number
- 01-0393723 (identifier) — IRS Employer Identification No.
- One IDEXX Drive, Westbrook, Maine 04092 (address) — Principal executive offices
- 207.556.03 (phone_number) — Business phone
FAQ
What specific financial results or conditions are being reported by IDEXX Laboratories in this 8-K?
The provided excerpt of the 8-K filing indicates that it pertains to 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits,' but it does not detail the specific financial figures or conditions.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on May 1, 2024.
What is the company's state of incorporation?
The company, IDEXX Laboratories, Inc., is incorporated in Delaware.
What is the principal executive office address for IDEXX Laboratories?
The principal executive office address is One IDEXX Drive, Westbrook, Maine 04092.
What is the Commission File Number for IDEXX Laboratories?
The Commission File Number for IDEXX Laboratories is 000-19271.
Filing Stats: 559 words · 2 min read · ~2 pages · Grade level 10.2 · Accepted 2024-05-01 06:30:44
Key Financial Figures
- $0.10 — ange on whichregistered Common Stock, $0.10 par value per share IDXX NASDAQ Glo
Filing Documents
- tm2413183d1_8k.htm (8-K) — 34KB
- tm2413183d1_ex99-1.htm (EX-99.1) — 349KB
- tm2413183d1_8kimg001.jpg (GRAPHIC) — 8KB
- tm2413183d1_ex99-1img001.jpg (GRAPHIC) — 3KB
- 0001104659-24-055201.txt ( ) — 605KB
- idxx-20240501.xsd (EX-101.SCH) — 3KB
- idxx-20240501_lab.xml (EX-101.LAB) — 33KB
- idxx-20240501_pre.xml (EX-101.PRE) — 22KB
- tm2413183d1_8k_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On May 1, 2024, IDEXX Laboratories, Inc. (the "Company") announced its financial results for the quarter ended March 31, 2024. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K. In accordance with general instructions to Form 8-K, the information in this Form 8-K and the Exhibit 99.1 attached hereto is being furnished under Item 2.02 and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d)Exhibits The following exhibit relating to Item 2.02 shall be deemed to be furnished, and not filed. ExhibitNo. Description of Exhibit 99.1 Press Release entitled "IDEXX Laboratories Announces First Quarter Results," issued by the Company on May 1, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IDEXX LABORATORIES, INC. Date: May 1, 2024 By: /s/ Brian P. McKeon Brian P. McKeon Executive Vice President, Chief Financial Officer and Treasurer 2